23 May 2013
Keywords: genzyme, starts, trials, breast, cancer, drug, molecular
Article | 16 September 1999
Genzyme Molecular Oncology has started a Phase I trial of a vaccinedesigned as an immunotherapy for breast cancer. The vaccine ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.